Original language | English |
---|---|
Number of pages | 2 |
Journal | Journal of Clinical Oncology |
Volume | 36 |
Issue number | 5 |
DOIs | |
Publication status | Published - 10 Feb 2018 |
Event | ASCO-SITC Clinical Immuno-Oncology Symposium - San Francisco, Canada Duration: 25 Jan 2018 → 27 Jan 2018 |
A phase 1b study of the anti-PD-1 monoclonal antibody BGB-A317 (A317) in combination with the PARP inhibitor BGB-290 (290) in advanced solid tumors.
Michael Friedlander, Tarek Meniawy, Ben Markman, Linda R. Mileshkin, Paul Harnett, Michael Millward, J. Lundy, A. E. Freimund, C. Norris, S Mu, V Paton, L Wang, Bo Gao
Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review
5
Citations
(Web of Science)